<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>CCI approves proposed subscription of Compulsorily Convertible Preference Shares (B) (CCPS B) in API Holdings Ltd. by CDPQ Private Equity Asia Pte Ltd.</title>
    <link>https://www.taxtmi.com/news?id=27201</link>
    <description>Approval was granted for a proposed subscription of Compulsorily Convertible Preference Shares (CCPS B) in API Holdings Ltd by an existing investor through a Rights Issue. The Acquirer, a foreign institutional investor acting via a Singapore subsidiary and holding pre-emption rights, will make a primary subscription accompanied by certain investor rights. The Target operates in healthcare services including an online pharmacy marketplace, B2B pharmaceutical wholesale and logistics, and diagnostic services. The competition regulator approved the transaction and noted a detailed order will follow.</description>
    <language>en-us</language>
    <pubDate>Wed, 31 Jan 2024 15:36:38 +0530</pubDate>
    <lastBuildDate>Wed, 31 Jan 2024 15:36:38 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=741909" rel="self" type="application/rss+xml"/>
    <item>
      <title>CCI approves proposed subscription of Compulsorily Convertible Preference Shares (B) (CCPS B) in API Holdings Ltd. by CDPQ Private Equity Asia Pte Ltd.</title>
      <link>https://www.taxtmi.com/news?id=27201</link>
      <description>Approval was granted for a proposed subscription of Compulsorily Convertible Preference Shares (CCPS B) in API Holdings Ltd by an existing investor through a Rights Issue. The Acquirer, a foreign institutional investor acting via a Singapore subsidiary and holding pre-emption rights, will make a primary subscription accompanied by certain investor rights. The Target operates in healthcare services including an online pharmacy marketplace, B2B pharmaceutical wholesale and logistics, and diagnostic services. The competition regulator approved the transaction and noted a detailed order will follow.</description>
      <category>News</category>
      <law>-</law>
      <pubDate>Wed, 31 Jan 2024 15:36:38 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/news?id=27201</guid>
    </item>
  </channel>
</rss>